Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Mitochondrial DNA alterations in aged macrophage migration inhibitory factor-knockout mice.

Herbst A, Hoang AN, Woo W, McKenzie D, Aiken JM, Miller RA, Allison DB, Liu N, Wanagat J.

Mech Ageing Dev. 2019 Sep;182:111126. doi: 10.1016/j.mad.2019.111126. Epub 2019 Aug 2.

PMID:
31381889
2.

Skeletal muscle mitochondrial DNA deletions are not increased in CuZn-superoxide dismutase deficient mice.

Wanagat J, Ahmadieh N, Bielas JH, Ericson NG, Van Remmen H.

Exp Gerontol. 2015 Jan;61:15-9. doi: 10.1016/j.exger.2014.11.012. Epub 2014 Nov 20.

3.

Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle.

Konokhova Y, Spendiff S, Jagoe RT, Aare S, Kapchinsky S, MacMillan NJ, Rozakis P, Picard M, Aubertin-Leheudre M, Pion CH, Bourbeau J, Hepple RT, Taivassalo T.

Skelet Muscle. 2016 Feb 18;6:10. doi: 10.1186/s13395-016-0083-9. eCollection 2016.

4.

Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.

Mun SH, Won HY, Hernandez P, Aguila HL, Lee SK.

J Bone Miner Res. 2013 Apr;28(4):948-59. doi: 10.1002/jbmr.1787.

5.

Digital PCR Quantitation of Muscle Mitochondrial DNA: Age, Fiber Type, and Mutation-Induced Changes.

Herbst A, Widjaja K, Nguy B, Lushaj EB, Moore TM, Hevener AL, McKenzie D, Aiken JM, Wanagat J.

J Gerontol A Biol Sci Med Sci. 2017 Oct 1;72(10):1327-1333. doi: 10.1093/gerona/glx058.

6.

Long term rapamycin treatment improves mitochondrial DNA quality in aging mice.

Bielas J, Herbst A, Widjaja K, Hui J, Aiken JM, McKenzie D, Miller RA, Brooks SV, Wanagat J.

Exp Gerontol. 2018 Jun;106:125-131. doi: 10.1016/j.exger.2018.02.021. Epub 2018 Feb 24.

7.

Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction.

Harper JM, Wilkinson JE, Miller RA.

FASEB J. 2010 Jul;24(7):2436-42. doi: 10.1096/fj.09-152223. Epub 2010 Mar 10.

8.

Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice.

Bay-Richter C, Janelidze S, Sauro A, Bucala R, Lipton J, Deierborg T, Brundin L.

J Neuroinflammation. 2015 Sep 4;12:163. doi: 10.1186/s12974-015-0387-4.

9.

Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice.

Turtzo LC, Li J, Persky R, Benashski S, Weston G, Bucala R, Venna VR, McCullough LD.

Neurobiol Dis. 2013 Jun;54:421-31. doi: 10.1016/j.nbd.2013.01.016. Epub 2013 Jan 30.

10.

Latent mitochondrial DNA deletion mutations drive muscle fiber loss at old age.

Herbst A, Wanagat J, Cheema N, Widjaja K, McKenzie D, Aiken JM.

Aging Cell. 2016 Dec;15(6):1132-1139. doi: 10.1111/acel.12520. Epub 2016 Aug 25.

11.

Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction.

White DA, Su Y, Kanellakis P, Kiriazis H, Morand EF, Bucala R, Dart AM, Gao XM, Du XJ.

J Mol Cell Cardiol. 2014 Apr;69:32-42. doi: 10.1016/j.yjmcc.2014.01.015. Epub 2014 Feb 5.

12.

Macrophage migration inhibitory factor (MIF) contributes to the development of allergic rhinitis.

Nakamaru Y, Oridate N, Nishihira J, Takagi D, Furuta Y, Fukuda S.

Cytokine. 2005 Jul 21;31(2):103-8.

PMID:
15922619
13.

An age-associated correlation between cellular bioenergy decline and mtDNA rearrangements in human skeletal muscle.

Kopsidas G, Kovalenko SA, Kelso JM, Linnane AW.

Mutat Res. 1998 Oct 12;421(1):27-36.

PMID:
9748486
14.

Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation.

Gao XM, Liu Y, White D, Su Y, Drew BG, Bruce CR, Kiriazis H, Xu Q, Jennings N, Bobik A, Febbraio MA, Kingwell BA, Bucala R, Fingerle-Rowson G, Dart AM, Morand EF, Du XJ.

J Mol Cell Cardiol. 2011 Jun;50(6):991-9. doi: 10.1016/j.yjmcc.2010.12.022. Epub 2011 Jan 6.

PMID:
21215754
15.

The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.

Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, Huss R, Moll U, Müller W, Bucala R.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9354-9. Epub 2003 Jul 23.

16.

Impaired fracture healing in macrophage migration inhibitory factor-deficient mice.

Kobayashi T, Onodera S, Kondo E, Tohyama H, Fujiki H, Yokoyama A, Yasuda K.

Osteoporos Int. 2011 Jun;22(6):1955-65. doi: 10.1007/s00198-010-1385-0. Epub 2010 Sep 14.

PMID:
20838768
17.

Macrophage migration inhibitory factor inhibits osteoclastogenesis.

Jacquin C, Koczon-Jaremko B, Aguila HL, Leng L, Bucala R, Kuchel GA, Lee SK.

Bone. 2009 Oct;45(4):640-9. doi: 10.1016/j.bone.2009.06.028. Epub 2009 Jul 7.

PMID:
19591967
18.

Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.

Taylor JA 3rd, Kuchel GA, Hegde P, Voznesensky OS, Claffey K, Tsimikas J, Leng L, Bucala R, Pilbeam C.

BMC Cancer. 2007 Jul 24;7:135.

19.

Macrophage migration inhibitory factor mediates protease-activated receptor 4-induced bladder pain through urothelial high mobility group box 1.

Ma F, Kouzoukas DE, Meyer-Siegler KL, Hunt DE, Leng L, Bucala R, Vera PL.

Physiol Rep. 2017 Dec;5(24). pii: e13549. doi: 10.14814/phy2.13549.

20.

Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.

Taylor JA, Zhu Q, Irwin B, Maghaydah Y, Tsimikas J, Pilbeam C, Leng L, Bucala R, Kuchel GA.

Am J Physiol Renal Physiol. 2006 Dec;291(6):F1343-53. Epub 2006 Jul 11.

Supplemental Content

Support Center